Strategie multifattoriali per la prevenzione dei rischi di ulcerazione in pazienti affetti da piede diabetico

Title

Code

DARE-DiaFoot

Type

Sperimentale

Start Year

2025

Status

In Corso

Principal Investigator

051-6366529

lisa.berti@ior.it

Berti Lisa, MD

Director

Functional Recovery and Rehabilitation 1

Operational unit that carry out the study

complex unit

Medicina fisica e riabilitativa 1

Director

Berti Lisa, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. DARE-DiaFoot

Monday 20 January 2025, 15:50

PG0000034_2025_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Strategie multifattoriali per la prevenzione dei rischi di ulcerazione in pazienti affetti da piede diabetico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Strategie multifattoriali per la prevenzione dei rischi di ulcerazione in pazienti affetti da piede diabetico

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in